CD8A and hepatocellular carcinoma: Infiltrating and tissue-resident CD8+ T cells are the primary effectors of the antitumour immune response, and their presence correlates with improved prognosis and response to treatment.[33], [34], [35] However, CD8+ T cells are often highly dysfunctional within the HCC TME and thus ineffective at tumour clearance.